- Home
- GBTG vs PTGX Comparison
GBTG vs PTGX Comparison
Compare GBTG & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GBTG | PTGX |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 5.4B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | GBTG | PTGX |
|---|---|---|
| Price | $7.92 | $89.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $10.25 | ★ $86.44 |
| AVG Volume (30 Days) | ★ 1.6M | 898.7K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.01 | ★ 0.72 |
| Revenue | ★ $2,517,000,000.00 | $209,217,000.00 |
| Revenue This Year | $14.24 | N/A |
| Revenue Next Year | $19.87 | $296.47 |
| P/E Ratio | $414.63 | ★ $124.48 |
| Revenue Growth | ★ 5.71 | N/A |
| 52 Week Low | $5.78 | $33.70 |
| 52 Week High | $9.57 | $93.25 |
Technical Indicators
Market Signals| Indicator | GBTG | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 57.18 | 64.67 |
| Support Level | $7.85 | $83.52 |
| Resistance Level | $8.06 | $90.85 |
| Average True Range (ATR) | 0.23 | 2.63 |
| MACD | 0.09 | -0.33 |
| Stochastic Oscillator | 88.84 | 83.62 |
Price Performance
Historical ComparisonAbout GBTG Global Business Travel Group Inc.
Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.